REPL
#2588
Replimune Group, Inc. - Common Stock
9.9 4 USD
-0.10%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-9.55%
Monthly Change
+12.83%
6 month change
+29.77%
Year Change
-13.34%
Previous Close
10.9 9
Open
9.9 4
Low
9.9 4
High
9.9 4
Volume
110
Financials
- Market Capitalization 834.41 M
- Employee 465
- Founded 2015
- CEO N/A
- Website www.replimune.com
- Headquarter Delaware, United States
- FIGI BBG00L8Z22R1
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.26
Price to sales ratio
753.66
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2559 |  PHAT Phathom Pharmaceuticals, Inc. - Common Stock | 10.92 USD | -13.40% | -5.37% | +5.81% | +20.80% | 870.94 M USD | ||
| 2561 |  DSGN Design Therapeutics, Inc. - Common Stock | 13.86 USD | -8.76% | -7.41% | +24.98% | +248.24% | 865.65 M USD | ||
| 2592 |  IVA Inventiva S.A. - American Depository Shares | 4.30 USD | 0.00% | +11.11% | +11.69% | +28.74% | 830.92 M USD | ||
| 2609 |  CTMX CytomX Therapeutics, Inc. - Common Stock | 3.70 USD | -1.60% | -3.90% | +21.31% | +56.12% | 805.50 M USD |
Frequently asked questions about Replimune Group, Inc. - Common Stock
What is the Replimune Group, Inc. - Common Stock stock price today?
The current price of Replimune Group, Inc. - Common Stock (REPL) is 9.94. Over the past 24 hours, the stock has changed by -9.55%. Follow the REPL chart for real-time price dynamics.
What is the stock ticker of Replimune Group, Inc. - Common Stock?
Replimune Group, Inc. - Common Stock trades under the ticker REPL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Replimune Group, Inc. - Common Stock stock going up?
REPL has changed by -14.38% over the last week, +12.83% over the last month, and -13.34% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Replimune Group, Inc. - Common Stock net income for the last quarter?
Replimune Group, Inc. - Common Stock reported net income of -73.22 M for the last quarter. The previous quarter showed -70.93 M, which means net income changed by -3.22%.
How many employees does Replimune Group, Inc. - Common Stock have?
As of the latest available data, Replimune Group, Inc. - Common Stock has 465 employees. Workforce size can provide additional context about the company's scale and operations.
What is Replimune Group, Inc. - Common Stock EBITDA?
Replimune Group, Inc. - Common Stock EBITDA is -72.4 M, and its EBITDA margin is -94.03 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Replimune Group, Inc. - Common Stock stock?
You can buy Replimune Group, Inc. - Common Stock (REPL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Replimune Group, Inc. - Common Stock stock?
Investing in Replimune Group, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the REPL chart and related analysis on metatrader.com as part of your research.